<DOC>
	<DOC>NCT02453711</DOC>
	<brief_summary>This trial is conducted globally. The aim of this trial is to investigate safety and efficacy of once-daily semaglutide in obese subjects without diabetes mellitus.</brief_summary>
	<brief_title>Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Informed consent obtained before any trialrelated activities. Trialrelated activities are any procedures that are carried out as part of the trial, including activities to determine suitability for the trial Male or female, age 18 years or older at the time of signing inform consent Body mass index (BMI) equal or above 30.0 kg/m^2 at the screening visit At least one unsuccessful weight loss attempt per investigator judgement A HbA1c (glycosylated haemoglobin) equal to or above 6.5% at screening or diagnosed with type 1 or type 2 diabetes mellitus Treatment with glucose lowering agent(s) within 90 days before screening Screening calcitonin equal to or above 50 ng/L (pg/mL) Personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 History of pancreatitis (acute or chronic) Obesity induced by endocrine disorders (e.g. Cushing Syndrome) Treatment with any medication within 90 days before screening that based on investigator's judgement may cause significant weight change Previous surgical treatment for obesity (liposuction and/or abdominoplasty performed 1 year before screening is allowed) History of major depressive disorder within 2 years before randomisation Any lifetime history of a suicidal attempt Female who is pregnant, breastfeeding or intends to become pregnant or is of childbearing potential and not using an adequate contraceptive method (adequate contraceptive measures as required by local regulation or practice)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>